Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $100.67 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $75.42 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $14.49 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $10.76 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.59 | 1 | ABBVIE INC. ($13.59) |
| 2019 | $37.54 | 2 | AbbVie, Inc. ($23.05) |
| 2018 | $38.78 | 3 | AbbVie, Inc. ($38.78) |
| 2017 | $10.76 | 1 | Janssen Biotech, Inc. ($10.76) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/18/2019 | AbbVie, Inc. | Skyrizi (Biological) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Immunology | ||||||
| 01/09/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: DERMATOLOGY | ||||||
| 07/11/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Immunology | ||||||
| 05/24/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $11.95 | General |
| 03/01/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Immunology | ||||||
| 06/20/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 14 | 1,297 | 2,170 | $171,645 | $87,523 |
| 2020 | 12 | 1,256 | 1,790 | $161,520 | $88,223 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 308 | 391 | $39,010 | $23,132 | 59.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 160 | 206 | $25,840 | $13,614 | 52.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 111 | 137 | $16,505 | $11,100 | 67.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 193 | 297 | $28,465 | $10,068 | 35.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 145 | 169 | $11,055 | $6,501 | 58.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 82 | $11,380 | $5,434 | 47.7% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 68 | 112 | $8,980 | $4,576 | 51.0% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 42 | 44 | $6,820 | $4,288 | 62.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 124 | 658 | $13,350 | $3,124 | 23.4% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 17 | 19 | $3,775 | $2,528 | 67.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 15 | $3,590 | $1,619 | 45.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $1,320 | $855.41 | 64.8% |
| 69100 | Biopsy of ear | Office | 2021 | 12 | 12 | $1,380 | $585.86 | 42.5% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2021 | 16 | 17 | $175.00 | $99.11 | 56.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 398 | 462 | $55,965 | $35,319 | 63.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 158 | 201 | $25,245 | $13,916 | 55.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 147 | 187 | $16,920 | $9,218 | 54.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 105 | 116 | $13,985 | $9,151 | 65.4% |
| 17000 | Destruction of skin growth | Office | 2020 | 175 | 230 | $22,000 | $8,518 | 38.7% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 57 | 90 | $7,220 | $3,683 | 51.0% |
| 11104 | Punch biopsy of single skin lesion | Office | 2020 | 36 | 37 | $5,735 | $3,376 | 58.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 92 | 378 | $7,670 | $1,744 | 22.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 51 | 52 | $3,415 | $1,643 | 48.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $1,755 | $1,018 | 58.0% |
| 69100 | Biopsy of ear | Office | 2020 | 12 | 12 | $1,500 | $573.49 | 38.2% |
About Dr. Nancy Cunningham, M.D
Dr. Nancy Cunningham, M.D is a Dermatology healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407817299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Cunningham, M.D has received a total of $100.67 in payments from pharmaceutical and medical device companies, with $13.59 received in 2024. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($100.67).
As a Medicare-enrolled provider, Cunningham has provided services to 2,553 Medicare beneficiaries, totaling 3,960 services with total Medicare billing of $175,746. Data is available for 2 years (2020–2021), covering 26 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Wilmington, NC
- Active Since 03/31/2006
- Last Updated 06/10/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1407817299
Products in Payments
- Humira (Biological) $26.83
- Skyrizi (Biological) $23.05
- COSENTYX (Biological) $14.49
- BOTOX (Biological) $13.59
- STELARA (Biological) $10.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Wilmington
Rosalyn George, M.d, M.D
Dermatology — Payments: $417,485
Laura Tanner, M.d, M.D
Dermatology — Payments: $85,157
Mr. James Appel, M.d, M.D
Dermatology — Payments: $35,878
Dr. Aron Gewirtzman, M.d, M.D
Dermatology — Payments: $24,635
Dr. Michael Rosenthal, D.o, D.O
Dermatology — Payments: $21,448
Dr. Jonathan Crane, D.o, D.O
Dermatology — Payments: $12,737